Mythili Shastry

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

Kent C. Shih, Sajeel Chowdhary, Paul Rosenblatt et al. · Journal of Neuro-Oncology · 2016 · 122 citations

Neuro-oncology, Phase Ii Trial, Neurology +4

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer

Mythili Shastry, Saya Jacob, Hope S. Rugo et al. · The Breast · 2022 · 120 citations · Full text

Rise of Antibody-Drug Conjugates: The Present and Future

Mythili Shastry, Avantika Gupta, Sarat Chandarlapaty et al. · American Society of Clinical Oncology Educational Book · 2023 · 93 citations · Full text

Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer

Denise A. Yardley, Eric Raefsky, Raul Castillo et al. · Clinical Breast Cancer · 2011 · 57 citations

Neoadjuvant Weekly Nab-paclitaxel, Breast Oncology, Oncology +5

A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score

Denise A. Yardley, N. W. Peacock, Mythili Shastry et al. · Breast Cancer Research and Treatment · 2015 · 55 citations

21-Gene Recurrence Score, Breast Oncology, Phase Ii Trial +8